Press Release
October 14, 2008

Goodwin Procter Adds Five from Heller Ehrman

Firm Welcomes High Profile Attorneys to Technology, Life Sciences and Labor Practices in New York and Silicon Valley

BOSTON, Oct. 14, 2008 – Goodwin Procter announced today that five attorneys have joined the firm from Heller Ehrman. Stephen M. Davis, Kevin T. Collins and Wesley C. Fredericks, Jr. have joined in the New York office; and Steven R. Feldstein has joined the firm’s Silicon Valley office as a partner in the Labor & Employment Practice.

Davis formerly served as co-chair of Heller Ehrman’s Corporate/Venture Capital Law Group (VLG) and is a former chair of its New York Business Practice. His extensive corporate and securities practice focuses on representing technology and life sciences and clean technology companies. He advises his clients on matters relating to corporate finance and securities, mergers and acquisitions, corporate governance, and joint ventures, along with institutional investors focused on these markets.

Collins also was a member of Heller Ehrman’s Corporate/VLG Practice Group, and co-chair of the Life Sciences Practice. He advises clients primarily in the life sciences industry on issues presented over the entire life cycle of an enterprise, including general corporate matters, private and public securities and strategic partnering and various licensing matters.

Fredericks previously was chairman of Heller Ehrman’s New York Business Law Practice, a member of its Corporate/VLG Practice Group, and has extensive experience in representing technology companies – with an industry focus in life sciences. He advises his clients with respect to domestic and international mergers and acquisitions, joint ventures, public and private financings, corporate governance and board of directors counseling, and regulatory compliance.

Feldstein was the former co-chair of Heller Ehrman’s Labor & Employment Practice Group nationwide. He advises clients nationally on a number of mission-critical matters including, employee relations, trade secrets protection, avoiding and litigating wrongful termination and employment discrimination claims, labor union issues, employee handbooks and policies and workforce reductions. He also represents companies on the employment-related ramifications of corporate mergers and acquisitions.

For the past 30 years, Stern has focused his practice on high-technology and health-related companies. He has extensive experience in the U.S. and foreign licensing of patents and other proprietary rights by and to high-technology companies, as well as the exploitation of their technology through joint venture, corporate partnering, research and development and distribution agreements.

“We are extremely pleased to welcome these very talented and experienced attorneys to Goodwin Procter,” said Regina M. Pisa, chairman and managing partner. “Their expertise is a perfect complement to our existing practice strengths and they are tremendous assets to our New York and Silicon Valley offices.”

Since 2005, Goodwin Procter has aggressively grown its technology and venture capital practice, including the addition of nearly 100 attorneys from Testa Hurwitz & Thibeault and a significant number of lateral hires on both coasts over the past two years. Today, over 200 of its 900 attorneys focus on serving the technology, life sciences, private equity and venture capital communities.

Since establishing its first West Coast office in April 2006, Goodwin Procter has been boldly expanding throughout California. The firm currently has 100 lawyers in California, with 43 resident in Silicon Valley office, which opened in June 2007.

About Goodwin Procter
Goodwin Procter LLP is one of the nation’s leading law firms with 900 attorneys in offices in Boston, Los Angeles, New York, San Diego, San Francisco, Silicon Valley, and Washington, D.C. The firm’s core areas of practice are corporate, litigation and real estate, with specialized areas of focus that include financial services, private equity, technology, REITs and real estate capital markets, intellectual property, tax and products liability. Information may be found at

Goodwin Procter has long been recognized as a leader in sophisticated finance-oriented and transactional work, and is a national leader in advising technology and life sciences companies. This year, Goodwin Procter ranked as the 8th most active law firm for deals valued at $100 million or more (Corporate Control Alert); the 5th most active law firm for private equity and venture capital transactions, based on volume of deals closed; (Private Equity Analyst, 2007); the 7th most active issuer’s counsel for U.S. IPOs (IPO Vital Signs); and “Law Firm of the Year” (Fund Formation) Global Private Equity Real Estate Awards (Private Equity Real Estate Magazine, 2007).